Pletal for claudication
Pletal for claudication
The ability of Pletal to improve walking distance in patients with stable intermittent claudication was studied in eight large, randomized, placebo-controlled, double-blind trials of pletal for claudication 12 to 24 weeks’ duration using dosages of 50 mg b. The ability of Pletal to improve walking distance in patients with stable intermittent claudication was studied in eight large, randomized, placebo-controlled, double-blind trials of 12 to 24 weeks’ duration using dosages of 50 mg b. Secondary prevention of non-cardioembolic ischemic stroke or transient ischemic attack (TIA) Interpretation: Cilostazol (Pletal™) is the first drug to demonstrate a clear benefit for intermittent claudication. Secondary prevention of non-cardioembolic ischemic stroke or transient ischemic attack (TIA) Interpretation: Cilostazol (Pletal™) is the first drug to demonstrate a clear benefit for intermittent claudication. Secondary prevention of non-cardioembolic ischemic stroke or transient ischemic attack (TIA) Claudication therapy: For lifestyle-limiting claudication: Cilostazol (Pletal): 100 mg b. Secondary prevention of non-cardioembolic ischemic stroke or transient ischemic attack (TIA) Claudication therapy: For lifestyle-limiting claudication: Cilostazol (Pletal): 100 mg b. Prescriptions for cilostazol are limited to the Vascular Service. Prescriptions for cilostazol are limited to the Vascular Service. Pletal may also be used for pletal for claudication purposes not listed in this medication guide Cilostazol (Pletal) is a selective inhibitor of phosphodiesterase-III with antiplatelet, antithrombotic and vasodilating properties. Pletal may also be used for purposes not listed in this medication guide Cilostazol (Pletal) is a selective inhibitor of phosphodiesterase-III with antiplatelet, antithrombotic and vasodilating properties. The recommended dosage of Pletaal OD is 100 mg bid, taken at least half an hour before or two hours after breakfast and dinner. The recommended dosage of Pletaal OD is 100 mg bid, taken at least half an hour before or two hours after breakfast and dinner. Because PAD interferes with circulation, in severe cases procedures may be required to improve blood flow.. Because PAD interferes with circulation, in severe cases procedures may be required to improve blood flow.. This medicine improves your ability to walk longer distances without pain. This medicine improves your ability to walk longer distances without pain. A dose of 50 mg bid should be considered during coadministration of Fluconazole, Ketoconazole, Itraconazole, Erythromycin, Clarithromycin, Fluvoxamine, Fluoxetine, Nefazodone, Sertraline and Diltiazem.. A dose of 50 mg bid should be considered during coadministration of Fluconazole, Ketoconazole, Itraconazole, Erythromycin, Clarithromycin, Fluvoxamine, Fluoxetine, Nefazodone, Sertraline and Diltiazem.. Blockage of the blood vessels to the legs, causes a distinctive type of pain called intermittent claudication. Blockage of the blood vessels to the legs, causes a distinctive type of pain called intermittent claudication. A dose of 50 mg bid should be considered during coadministration of Fluconazole, Ketoconazole, Itraconazole, Erythromycin, Clarithromycin, Fluvoxamine, Fluoxetine, Nefazodone, Sertraline and Diltiazem.. A dose of 50 mg bid should be considered during coadministration of Fluconazole, Ketoconazole, Itraconazole, Erythromycin, Clarithromycin, Fluvoxamine, Fluoxetine, Nefazodone, Sertraline and Diltiazem.. The recommended dosage of Pletaal OD is 100 mg bid, taken at least half an hour before or two hours after breakfast and dinner. The recommended dosage of Pletaal OD is 100 mg bid, taken at least half an hour before or two hours after breakfast and dinner. Pletal Tablet may also be used for purposes not listed in this medication guide. Pletal Tablet may also be used for purposes not listed in this medication guide. Blockage of the blood vessels to the legs, causes a distinctive type of pain called intermittent claudication. Blockage of the blood vessels to the legs, causes a distinctive type of pain called intermittent claudication. The recommended dosage of Pletaal OD is 100 mg bid, taken at least half an hour before or two hours after breakfast and dinner. The recommended dosage of Pletaal OD is 100 mg bid, taken at least half an hour before or two hours after breakfast and dinner. With cilostazol, subjects with intermittent claudication could walk 333 meters compared. With cilostazol, subjects with intermittent claudication could walk 333 meters compared. It also exhibits antiproliferative effects on smooth muscle cells and has beneficial effects on high density lipoprotein-cholesterol and triglyceride levels. It also exhibits antiproliferative effects on smooth muscle cells and has beneficial effects on high density lipoprotein-cholesterol and triglyceride levels. Pletal Dosage and Administration Recommended dosage. Pletal Dosage and Administration Recommended dosage. The suggested dose of cilostazol for intermittent claudication is 100 mg taken orally twice daily Pletal dosage. The suggested dose of cilostazol for intermittent claudication is 100 mg taken orally twice daily Pletal dosage. Pletal is indicated for the reduction of symptoms of intermittent claudication, as demonstrated by an increased walking distance. Pletal is indicated for the reduction of symptoms of intermittent claudication, as demonstrated by an increased walking distance. The recommended dosage of Pletal is 100 mg bid, taken at least half pletal for claudication an hour before or two hours after breakfast and dinner. The recommended dosage of Pletal is 100 mg bid, taken at least half an hour before or two hours after breakfast and dinner. Select drug class All drug classes miscellaneous cardiovascular agents (1) miscellaneous coagulation modifiers (1) platelet aggregation inhibitors (1). Select drug class All drug classes miscellaneous cardiovascular agents (1) miscellaneous coagulation modifiers (1) platelet aggregation inhibitors (1). Cilostazol is indicated for intermittent claudication but there is also evidence to suggest that cilostazol may have a role in reducing restenosis after endovascular therapy and coronary stenting ( Iida 2008; Lee 2013 ). Cilostazol is indicated for intermittent claudication but there is also evidence to suggest that cilostazol may have a role in reducing restenosis after endovascular therapy and coronary stenting ( Iida 2008; Lee 2013 ).